Health Care & Life Sciences » Biotechnology | Endonovo Therapeutics Inc.

Endonovo Therapeutics Inc.

Endonovo Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$9.77 M
Shares Outstanding
558.16 M
Public Float
385.89 M

Profile

Address
6320 Canoga Avenue
Woodland Hills California 91367
United States
Employees -
Website http://www.endonovo.com
Updated 07/08/2019
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in developing off bioelectronic approach to regenerative medicine. It operates through the Intellectual Property Management and Commercialization segment. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.

Financials

View All

Alan Brian Collier
Chairman, CEO, CFO & Secretary
Alan Brian Collier
Chairman, CEO, CFO & Secretary